✦ LIBER ✦

Treatment of Lamivudine-Resistant Hepatitis B Infection in Post–Renal Transplant Patients With Adefovir Dipivoxil: Premiminary Results

✍ Scribed by H.J. de Silva; A.S. Dassanayake; A. Manamperi; A.P. de Silva

Book ID: 116932809
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 150 KB
Volume: 38
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2006.08.186

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment With Adefovir Dipivoxil in a R

Treatment With Adefovir Dipivoxil in a Renal Transplant Patient With Renal Insufficiency and Lamivudine-Resistant Hepatitis B Infection

✍ A. Garcia; A. Mazuecos; P. González; F. Diaz; T. Garcia; M. Ceballos; M. Rivero 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Extended treatment with lamivudine and a

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ Robert P. Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 309 KB

Adefovir dipivoxil therapy for lamivudin

Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post–liver transplantation patients

✍ Eugene R. Schiff; Ching-Lung Lai; Stefanos Hadziyannis; Peter Neuhaus; Norah Ter 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

448 Rescue treatment with adefovir dipiv

448 Rescue treatment with adefovir dipivoxil in lamivudine resistant patients with chronic hepatitis B

✍ M. Vigano; P. Lampertico; M. Iavarone; G. Lunghi; G. Colucci; E. Del Ninno; M. C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Adefovir dipivoxil for wait-listed and p

Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

✍ Eugene Schiff; Ching-Lung Lai; Stephanos Hadziyannis; Peter Neuhaus; Norah Terra 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

Wait-listed (n ϭ 226) or post-liver transplantation (n ϭ 241) chronic hepatitis B (CHB) patients with lamivudine-resistant hepatitis B virus (HBV) were treated with adefovir dipivoxil for a median of 39 and 99 weeks, respectively. Among wait-listed patients, serum HBV DNA levels became undetectable

Study on the Efficacy and Safety of Adef

Study on the Efficacy and Safety of Adefovir Dipivoxil Treatment in Post–Liver Transplant Patients With Hepatitis B Virus Infection and Lamivudine-Resistant Hepatitis B Virus

✍ R. Bárcena; S. Del Campo; G. Moraleda; T. Casanovas; M. Prieto; M. Buti; J.M. Mo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 61 KB